Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference67 articles.
1. Mata-Cases M, Casajuana M, Franch-Nadal J, et al. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain. Eur J Health Econ. 2016;17:1001–10.
2. Reyes-García R, Moreno-Pérez O, Tejera-Pérez O, et al. Sociedad Española de Endocrinología y Nutrición. Documento de abordaje integral de la DM2. Grupo de trabajo de diabetes de la SEEN. 2019. https://www.seen.es/docs/apartados/791/Abordaje%20Integral%20DM2_SEEN_2019_OCT_ISBN%20.pdf. Accessed 24 Oct 2021.
3. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:83.
4. Cebrián-Cuenca AM, Mata-Cases M, Franch-Nadal J, Mauricio D, Orozco-Beltrán D, Consuegra-Sánchez L. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population. Eur J Prev Cardiol. 2022;28:e32–4.
5. Artime E, Romera I, Díaz-Cerezo S, Delgado E. Epidemiology and economic burden of cardiovascular disease in patients with type 2 diabetes mellitus in Spain: a systematic review. Diabetes Ther. 2021;12:1631–59.